Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 5
2005 3
2006 4
2007 3
2008 2
2009 1
2010 1
2011 3
2012 5
2013 5
2014 7
2015 5
2016 4
2017 2
2019 1
2020 2
2021 2
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Management of glioblastoma.
Aoki T, Hashimoto N, Matsutani M. Aoki T, et al. Among authors: matsutani m. Expert Opin Pharmacother. 2007 Dec;8(18):3133-46. doi: 10.1517/14656566.8.18.3133. Expert Opin Pharmacother. 2007. PMID: 18035958 Review.
Molecular markers in pediatric neuro-oncology.
Ichimura K, Nishikawa R, Matsutani M. Ichimura K, et al. Among authors: matsutani m. Neuro Oncol. 2012 Sep;14 Suppl 4(Suppl 4):iv90-9. doi: 10.1093/neuonc/nos204. Neuro Oncol. 2012. PMID: 23095836 Free PMC article. Review.
Consensus on the management of intracranial germ-cell tumours.
Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC. Murray MJ, et al. Among authors: matsutani m. Lancet Oncol. 2015 Sep;16(9):e470-e477. doi: 10.1016/S1470-2045(15)00244-2. Lancet Oncol. 2015. PMID: 26370356 Review.
Pineal germ cell tumors.
Matsutani M. Matsutani M. Prog Neurol Surg. 2009;23:76-85. doi: 10.1159/000210054. Epub 2009 Mar 23. Prog Neurol Surg. 2009. PMID: 19329862 Review.
Low tumor cell content predicts favorable prognosis in germinoma patients.
Takami H, Satomi K, Fukuoka K, Fukushima S, Matsushita Y, Yamasaki K, Nakamura T, Tanaka S, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K. Takami H, et al. Among authors: matsutani m. Neurooncol Adv. 2021 Aug 10;3(1):vdab110. doi: 10.1093/noajnl/vdab110. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34549182 Free PMC article.
Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N, Kaneko MK, Mishima K, Nishikawa R, Matsutani M, Price JE, Kato Y. Hayatsu N, et al. Among authors: matsutani m. Biochem Biophys Res Commun. 2008 Sep 19;374(2):394-8. doi: 10.1016/j.bbrc.2008.07.049. Epub 2008 Jul 17. Biochem Biophys Res Commun. 2008. PMID: 18639524
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Nagane M, Ichimura K, Onuki R, Narushima D, Honda-Kitahara M, Satomi K, Tomiyama A, Arai Y, Shibata T, Narita Y, Uzuka T, Nakamura H, Nakada M, Arakawa Y, Ohnishi T, Mukasa A, Tanaka S, Wakabayashi T, Aoki T, Aoki S, Shibui S, Matsutani M, Ishizawa K, Yokoo H, Suzuki H, Morita S, Kato M, Nishikawa R. Nagane M, et al. Among authors: matsutani m. Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522. Cancers (Basel). 2022. PMID: 36428615 Free PMC article.
57 results